House dust mite subcutaneous immunotherapy

house dust mite extract immunotherapy · ALK-Abelló A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for House dust mite subcutaneous immunotherapy, covering 2008-10-16 to 2008-10-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety Trial of Subcutaneous Immunotherapy in Mite Induced Asthma [Phase 4]